tiprankstipranks
ePlus reports Q3 adjusted EPS $1.18, consensus $1.38
PremiumThe FlyePlus reports Q3 adjusted EPS $1.18, consensus $1.38
3M ago
ePlus Reports Third Quarter and First Nine Months Financial Results
PremiumPress Releases
ePlus Reports Third Quarter and First Nine Months Financial Results
3M ago
PLUS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PLUS Earnings this Week: How Will it Perform?
3M ago
ePlus Reports Second Quarter and First Half Financial Results
PremiumPress ReleasesePlus Reports Second Quarter and First Half Financial Results
6M ago
Is PLUS a Buy, Before Earnings?
PremiumPre-Earnings
Is PLUS a Buy, Before Earnings?
6M ago
Biocept (NASDAQ:BIOC) Skyrockets on Licensing Deal with Plus Therapeutics
PremiumMarket News
Biocept (NASDAQ:BIOC) Skyrockets on Licensing Deal with Plus Therapeutics
8M ago
Is PLUS a Buy, Before Earnings?
PremiumPre-EarningsIs PLUS a Buy, Before Earnings?
9M ago
ePlus Reports Fourth Quarter and Fiscal Year 2023 Financial Results
PremiumPress Releases
ePlus Reports Fourth Quarter and Fiscal Year 2023 Financial Results
12M ago
PLUS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PLUS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100